GROVE CITY, Ohio, Oct. 30, 2025 /PRNewswire/ — Tosoh Bioscience, Inc., a market leader in clinical diagnostics has received U.S. FDA 510(k) clearance for its next-generation Tosoh Automated Glycohemoglobin Analyzer HLC®-723 GR01 (GR01) for HbA1c testing.
SCOTTSDALE, Ariz., Oct. 30, 2025 /PRNewswire/ — In an exciting breakthrough for eye health, Barnet Dulaney Perkins, a leader in ophthalmic innovation, uses an advanced cataract surgery technique that delivers faster recovery, increased precision, and exceptional long-term results. The approach, which incorporates cutting-edge technology, revolutionizes how cataracts are treated, benefiting millions of patients worldwide.
Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD.
An app that turns consumer Apple Watches into tools for highly sophisticated sleep stage monitoring was developed by a team of researchers led by professor Joyita Dutta at the University of Massachusetts Amherst
The BetterGuard Lite features an impossibly thin, lightweight design at an affordable price for athletes worldwide
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus CGM.
ORLANDO, Fla., Oct. 29, 2025 /PRNewswire/ — Optimotion Implants, a medical device company that designs and manufactures total knee replacement implants and associated surgical instrumentation is expanding operations in the Tampa Bay area. Optimotion Implants is the only company in the world utilizing the revolutionary Lateral Approach technique in total knee replacement. Participating surgeons are highly trained on the Lateral Approach which allows them to do what others cannot, leading to better outcomes for patients.
AUBURN, Ala., Oct. 29, 2025 /PRNewswire/ — Students from Auburn University’s Mechanical Engineering and Industrial Design programs recently witnessed something pretty special: the public unveiling of a surgical device prototype they helped to develop.
Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men.
Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, offering a simple, noninvasive way to identify the disease. The breakthrough, published in Biosensors and Bioelectronics: X, could make heart failure screening more accessible, especially in remote and under-resourced communities.